In a 60-year-old man with diabetes mellitus and acute coronary syndrome, who has uncontrolled hyperglycemia and a thyroid panel showing normal free T3, elevated free T4, and suppressed TSH, what is the diagnosis and appropriate management?

Diagnosis: Nonthyroidal Illness Syndrome (Euthyroid Sick Syndrome)

In this critically ill patient with acute coronary syndrome, uncontrolled diabetes, and acute systemic illness, the thyroid panel showing suppressed TSH (0.019), elevated free T4 (2.57), and normal free T3 (3.56) most likely represents nonthyroidal illness syndrome (sick euthyroid syndrome), NOT true hyperthyroidism, and should NOT be treated with antithyroid medications at this time.

Clinical Reasoning

Why This Is NOT Hyperthyroidism

The key distinguishing feature is the normal free T3 level. In true hyperthyroidism, T3 is typically the first and most elevated hormone 1. When you see:

• Suppressed TSH
• Elevated free T4
• Normal or low T3
• Critically ill patient

This pattern strongly suggests nonthyroidal illness syndrome, where acute systemic illness (ACS, uncontrolled diabetes, metabolic stress) disrupts the hypothalamic-pituitary-thyroid axis and peripheral thyroid hormone metabolism.

Critical Context Factors

This 60-year-old man has multiple acute stressors that cause nonthyroidal illness:

• Acute coronary syndrome with positive troponin - a major physiologic stress 2, 3, 4
• Severe uncontrolled diabetes (A1C 11%) with acute hyperglycemia - known to worsen ACS outcomes 5
• Active symptoms: chest pain, dyspnea, vomiting, abdominal pain
• No thyroid symptoms - explicitly stated

The absence of thyroid symptoms is particularly telling. True hyperthyroidism severe enough to suppress TSH to 0.019 would typically produce symptoms, especially in the setting of cardiac stress 1.

Management Algorithm

Immediate Actions (First 24-48 Hours)

1. DO NOT start antithyroid medications (methimazole, propylthiouracil)

   • Risk of unnecessary immunosuppression and side effects
   • Will not improve outcomes in nonthyroidal illness

2. Focus on the primary problems:

   • ACS management per standard protocols (already addressed with your ST depression V5-V6)
   • Aggressive glycemic control - this is critical as hyperglycemia significantly worsens ACS mortality 6, 5
   • Target glucose 140-180 mg/dL initially in acute phase 6

3. Beta-blocker therapy - already indicated for ACS, will also address any potential thyroid-mediated tachycardia if present 1

Diagnostic Confirmation (48-72 Hours)

Repeat thyroid function tests in 48-72 hours while treating the acute illness:

• If TSH begins normalizing and T4 decreases → confirms nonthyroidal illness
• If T3 rises and TSH remains suppressed → reconsider true hyperthyroidism

If True Hyperthyroidism Is Suspected

Only if repeat testing shows elevated T3 with persistently suppressed TSH should you consider hyperthyroidism. In that scenario, given this patient's high-risk profile (elderly, ACS, diabetes, cardiovascular complications):

This patient would require pretreatment before definitive therapy 1:

• Start methimazole (not radioactive iodine acutely)
• Add beta-blocker (likely already on for ACS)
• Optimize all comorbid conditions before any radioactive iodine 1

The 2011 ATA/AACE guidelines specifically state that patients with "substantial comorbidity that puts them at greater risk for complications of worsening hyperthyroidism" including "cardiovascular complications such as atrial fibrillation, heart failure" and "poorly controlled diabetes mellitus" should have medical therapy optimized and be rendered medically stable before radioactive iodine 1.

Common Pitfalls to Avoid

1. Treating thyroid numbers in isolation - The clinical context (critically ill, no thyroid symptoms, normal T3) trumps isolated lab abnormalities

2. Starting antithyroid drugs empirically - This can cause agranulocytosis, hepatotoxicity, and delays appropriate treatment of the real problems (ACS, diabetes)

3. Ignoring the glycemic crisis - With A1C of 11% and acute ACS, uncontrolled glucose is a major mortality driver that requires immediate intensive management 6, 5

4. Ordering unnecessary thyroid imaging acutely - Ultrasound or uptake scans add no value in the acute setting and delay appropriate care

Follow-Up Plan

• Recheck thyroid panel in 4-6 weeks after hospital discharge when metabolically stable
• If abnormalities persist at that time, then pursue full hyperthyroidism workup (TSH receptor antibodies, thyroid uptake scan)
• Most cases of nonthyroidal illness normalize completely once the acute illness resolves 7

The priority is treating the life-threatening ACS and severe hyperglycemia, not chasing thyroid numbers that will likely normalize with resolution of acute illness.